HomeAKP • FRA
add
Anika Therapeutics Inc
Previous close
€12.60
Day range
€12.10 - €12.10
Year range
€11.70 - €26.40
Market cap
193.36M USD
Avg Volume
1.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 30.60M | — |
Operating expense | 17.83M | — |
Net income | -21.86M | — |
Net profit margin | -71.45 | — |
Earnings per share | -0.03 | -160.00% |
EBITDA | 2.09M | — |
Effective tax rate | 6,642.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 55.63M | -19.07% |
Total assets | 202.74M | -25.09% |
Total liabilities | 48.75M | -16.48% |
Total equity | 153.99M | — |
Shares outstanding | 14.18M | — |
Price to book | 1.18 | — |
Return on assets | -0.11% | — |
Return on capital | -0.13% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -21.86M | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1983
Headquarters
Website
Employees
288
